Ranjith Anand

Title: Ranjith Anand: Inventor in Xenotransplantation

Introduction

Ranjith Anand is an inventor based in Cambridge, Massachusetts. His work includes patenting genetic modifications intended to improve the survival and tolerance of xenografts, which are transplants between different species. He is associated with eGenesis, Inc., a company working in the field of xenotransplantation.

Latest Patents

Anand’s listed patent portfolio includes 2 patents. The supplied information identifies the following patent title: “Cells, Tissues, Organs, and Animals Having One or More Modified Genes for Enhanced Xenograft Survival and Tolerance.” The title appears twice in the provided data, so it is presented here once.

The patent disclosure concerns cells, tissues, organs, and animals with one or more modified genes intended to enhance xenograft survival or tolerance. It also describes methods for making and using these genetically modified biological materials.

Career Highlights

Anand’s patent work addresses a key challenge in xenotransplantation: improving the compatibility and persistence of transplanted tissues or organs across species. The disclosed genetic modifications and related methods reflect an approach that combines biotechnology research with potential applications in transplantation.

Collaborations

The supplied information lists David Heja and David Angeles Albores as Anand’s coworkers. His company affiliation is eGenesis, Inc.

Conclusion

Ranjith Anand’s listed inventions focus on genetic modifications designed to support xenograft survival and tolerance, connecting his patent activity with eGenesis, Inc.’s work in xenotransplantation.